Abstract
This letter refers to the recent demonstration that HIV-1 infected macrophages form specialized conduits that connect to B-cells (1). The conduit selectively transports the HIV-1 nef protein, providing nef with numerous means to interfere with cellular processes. Currently, no consideration of the connection between the conduit and the development of AIDS-related lymphoma (ARL) has been offered. ARL is one of the primary causes of death in the HIV-infected population and is related to B-cell proliferation and activation. In this letter we discuss several studies that link HIVinfected macrophages and specific forms of the nef protein to the development of ARL. The conduits discovered by Xu et al. [1] may lead to a better understanding of how HIV infection results in lymphomagenesis.
Keywords: HIV-1, AIDS-related lymphoma, macrophages, HIV-1 nef protein, Pathogenesis, B-cells, lymphomagenesis, virus-specific immunoglobin responses (IgG2 and IgA), CD40-dependent activation, metastatic, cytokines, cytidine deaminase-associated DNA, modification, Epstein Barr virus (EBV), tumorogenesis, immortalization, proliferation, tumor biopsies, Monocyte-derived, inflammation, malignancy, IFN, IL-4, IL-13, IL-10, viral load, MHC class II receptors, trans-golgi network (TGN), lysosomal degradation, myristoylation domain, cytosolic, dementia, mutation rate, RNAs
Current HIV Research
Title: HIV-1 Nef Protein Visits B-Cells via Macrophage Nanotubes: A Mechanism for AIDS-Related Lymphoma Pathogenesis?
Volume: 8 Issue: 8
Author(s): Susanna L. Lamers, Gary B. Fogel, Leanne C. Huysentruyt and Michael S. McGrath
Affiliation:
Keywords: HIV-1, AIDS-related lymphoma, macrophages, HIV-1 nef protein, Pathogenesis, B-cells, lymphomagenesis, virus-specific immunoglobin responses (IgG2 and IgA), CD40-dependent activation, metastatic, cytokines, cytidine deaminase-associated DNA, modification, Epstein Barr virus (EBV), tumorogenesis, immortalization, proliferation, tumor biopsies, Monocyte-derived, inflammation, malignancy, IFN, IL-4, IL-13, IL-10, viral load, MHC class II receptors, trans-golgi network (TGN), lysosomal degradation, myristoylation domain, cytosolic, dementia, mutation rate, RNAs
Abstract: This letter refers to the recent demonstration that HIV-1 infected macrophages form specialized conduits that connect to B-cells (1). The conduit selectively transports the HIV-1 nef protein, providing nef with numerous means to interfere with cellular processes. Currently, no consideration of the connection between the conduit and the development of AIDS-related lymphoma (ARL) has been offered. ARL is one of the primary causes of death in the HIV-infected population and is related to B-cell proliferation and activation. In this letter we discuss several studies that link HIVinfected macrophages and specific forms of the nef protein to the development of ARL. The conduits discovered by Xu et al. [1] may lead to a better understanding of how HIV infection results in lymphomagenesis.
Export Options
About this article
Cite this article as:
L. Lamers Susanna, B. Fogel Gary, C. Huysentruyt Leanne and S. McGrath Michael, HIV-1 Nef Protein Visits B-Cells via Macrophage Nanotubes: A Mechanism for AIDS-Related Lymphoma Pathogenesis?, Current HIV Research 2010; 8 (8) . https://dx.doi.org/10.2174/157016210794088209
DOI https://dx.doi.org/10.2174/157016210794088209 |
Print ISSN 1570-162X |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4251 |
Call for Papers in Thematic Issues
Management of HIV: Management of HIV: old challenges and new needs
The aim of this thematic issue is to provide the most recent updates regarding the effective management of HIV infection. Antiretroviral therapy (ART) has significantly decreased HIV-related mortality, leading to an enhancement in the quality of life and life expectancy for people living with HIV (PLWH). Despite the numerous advancements ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Modulation of Immuno-biome during Radio-sensitization of Tumors by Glycolytic Inhibitors
Current Medicinal Chemistry The Anti-malarial Drug Artesunate Blocks Wnt/β-catenin Pathway and Inhibits Growth, Migration and Invasion of Uveal Melanoma Cells
Current Cancer Drug Targets Monofunctional Platinum (PtII) Compounds – Shifting the Paradigm in Designing New Pt-based Anticancer Agents
Current Medicinal Chemistry Kruppel-Like Factors 4 and 5: Unity in Diversity
Current Genomics Approaches to Minimize Infection Risk in Blood Banking and Transfusion Practice
Infectious Disorders - Drug Targets The HIV-1 Tat Protein: A Multifaceted Target for Novel Therapeutic Opportunities
Current Drug Targets - Immune, Endocrine & Metabolic Disorders Pleiotropic Effects of Fenofibrate
Current Pharmaceutical Design Biodistribution Processes as Underestimated Confounders in Translational Stroke Research
Current Medicinal Chemistry Anti-Angiogenesis in Glioblastoma: The Clinical Consequences of Redundancy and Evasion?
Current Angiogenesis (Discontinued) Defining Pharmacokinetics for Individual Patient Dosimetry in Routine Radiopeptide and Radioimmunotherapy of Cancer: Australian Experience
Current Pharmaceutical Design Ribonucleases, Nucleases and Antiangiogenins in Antiproliferative Activities
Current Signal Transduction Therapy A Systematic Analysis of Physicochemical and ADME Properties of All Small Molecule Kinase Inhibitors Approved by US FDA from January 2001 to October 2015
Current Medicinal Chemistry Intravesical Drug Delivery into the Bladder to Treat Cancers
Current Drug Delivery Targeting the Brain: Advances in Drug Delivery
Current Pharmaceutical Biotechnology Fibrates in the Chemical Action of Daunorubicin
Current Cancer Drug Targets Panobinostat: The Small Molecule Metalloenzyme Inhibitor with Marvelous Anticancer Activity
Current Topics in Medicinal Chemistry Synthesis and Clinical Development of Palbociclib: An Overview
Medicinal Chemistry Immune Cell Entry to Central Nervous System - Current Understanding and Prospective Therapeutic Targets
Endocrine, Metabolic & Immune Disorders - Drug Targets Writers and Erasers of Histone Lysine methylation with Clinically Applied Modulators: Promising Target for Cancer Therapy
Current Pharmaceutical Design Recent Advances in the Discovery of Protein Kinase C Modulators Based on the Structures of Natural Protein Kinase C Activators
Current Medicinal Chemistry